Recommendations for modernizing infant vaccination schedules with combination vaccines in Colombia and Peru

The objective of this article was to consider the vaccination challenges in Colombia and Peru and the role of pediatric combination vaccines in overcoming these challenges. Barriers to including new vaccines with more antigens remain apparent in parts of these countries, where vaccine-preventable di...

Full description

Bibliographic Details
Published in:Revista Panamericana de Salud Pública
Main Authors: Carlos Torres-Martinez, Eduardo Chaparro, Ana-Cristina Mariño, Luiza Helena Falleiros-Arlant, Germán Camacho-Moreno, María E. Castillo, Carlos Garces, Wilfrido Coronell, Roberto Somocurcio
Format: Article in Journal/Newspaper
Language:English
Spanish
Portuguese
Published: Pan American Health Organization 2023
Subjects:
R
Online Access:https://doi.org/10.26633/RPSP.2023.24
https://doaj.org/article/f281f2a3341d48fea13346856626d3ac
Description
Summary:The objective of this article was to consider the vaccination challenges in Colombia and Peru and the role of pediatric combination vaccines in overcoming these challenges. Barriers to including new vaccines with more antigens remain apparent in parts of these countries, where vaccine-preventable diseases in infants continue to be a major problem. The challenges include the heterogeneity of vaccine coverage within each country and in neighboring countries, which can contribute to poor rates of vaccination coverage; the adverse impact of the inward migration of unvaccinated individuals, which has favored the re-emergence of vaccine-preventable diseases; vaccine shortages; and the impact of the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) pandemic and the associated shifts in health care resources. To improve the coverage of pediatric vaccines in Colombia and Peru, it will be necessary to ensure the widespread integration into vaccine schedules of combination vaccines containing diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b and hepatitis B antigens with a three-dose primary series delivered at 2, 4 and 6 months of age followed by a booster at 18 months of age. Such vaccines play important roles in preventing diphtheria, tetanus and pertussis; eradicating polio; and providing boosting against H. influenzae type b.